Karthik Kuppusamy - 04 Jun 2026 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
08 Jun 2026, 16:32:30 UTC
Prior SEC filing
24 Apr 2026
Next SEC filing
27 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Sean D. Mersten, Attorney in Fact for Karthik Kuppusamy

Key filing fact

Karthik Kuppusamy filed Form 4 for QUEST DIAGNOSTICS INC (DGX) on 08 Jun 2026.

Key facts

  • This page summarizes Karthik Kuppusamy's Form 4 filing for QUEST DIAGNOSTICS INC (DGX).
  • 5 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 08 Jun 2026, 16:32.

Change

  • Previous filing in this sequence was filed on 24 Apr 2026.
  • Current net transaction value: -$1,629,400.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001955217 Primary reporting owner

KUPPUSAMY KARTHIK

Relationship
SVP, Clinical Solutions
Address
500 PLAZA DRIVE, C/O QUEST DIAGNOSTICS INC, SECAUCUS
Signature
Sean D. Mersten, Attorney in Fact for Karthik Kuppusamy
Signature date
08 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DGX transaction

Common Stock

Options Exercise

Transaction value
Shares
+3,320
Change %
+25%
Price
$127.72*
Shares after
16,830
Date
04 Jun 2026
Ownership
Direct
Footnotes
F1
DGX transaction

Common Stock

Options Exercise

Transaction value
Shares
+4,827
Change %
+29%
Price
$121.80*
Shares after
21,657
Date
04 Jun 2026
Ownership
Direct
Footnotes
F1
DGX transaction

Common Stock

Sale

Transaction value
$1,629,400
Shares
-8,147
Change %
-38%
Price
$200.00
Shares after
13,510
Date
04 Jun 2026
Ownership
Direct
Footnotes
F1, F2
DGX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,721
Date
04 Jun 2026
Ownership
401(k)
Footnotes
F3
DGX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
358
Date
04 Jun 2026
Ownership
By Trust

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DGX transaction Derivative

Non-Qualifed Stock Option (right to buy)

Options Exercise

Transaction value
Shares
-3,320
Change %
-100%
Price
$127.72*
Shares after
0
Date
04 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,320
Exercise price
$127.72
Footnotes
F1, F4
DGX transaction Derivative

Non-Qualifed Stock Option (right to buy)

Options Exercise

Transaction value
Shares
-4,827
Change %
-100%
Price
$121.80*
Shares after
0
Date
04 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,827
Exercise price
$121.80
Footnotes
F1, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 5 footnotes

Footnote F1

This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

Footnote F2

The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.

Footnote F3

These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.

Footnote F4

The options vested in three annual installments beginning with the first on February 24, 2023, the second on February 24, 2024 and the final on February 24, 2025.

Footnote F5

The options vested in three annual installments beginning with the first on February 17, 2022, the second on February 17, 2023 and the final on February 17, 2024.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .